Online Desk: Experts at a seminar found Vonoprazan, a recently launched drug by Incepta Pharmaceuticals, a safer and more cost-effective treatment for peptic ulcers compared to all other available drugs in Bangladesh.

They made this observation at a scientific seminar titled ‘Role of Proton Pump inhibitors in the treatment of peptic ulcer disease and use of vonoprazan in gastroesophageal reflux disease (GERD), organised by Bangladesh Gastroenterology Society, in collaboration with Incepta Pharmaceuticals at a city hotel recently.

National professor A.K. Azad Khan presided over the seminar, which was also attended by assistant professor of Bangabandhu Sheikh Mujib Medical University Dr Nuruzzaman, associate professor of Sheikh Russel Gastroliver Institute and Hospital Dr Swapna Sarker, who were the keynote speakers.

Peptic ulcers and GERD are common diseases in our country. Vonoprazan is a very recently launched drug.

Other notable and expert discussants in the seminar were Dr. Habibur Rahman of Sir Salimullah College and Mitford Hospital’s former professor of gastroenterology department and former professor of Gastroenterology Department of Dhaka Medical College. Dr. Ashraful Islam, BSMMU Gastroenterology Department Chairman Professor Dr. Md. Anwarul Kabir, former professor at Sir Salimullah College Dr. Swapan Chandra Dhar, Major General Doctor of Combined Military Hospital. Rabiul Hossain and former professor of gastroenterology department of BSMMU Dr. MT Rahman.

Professor Chanchal Kumar Ghosh, Secretary General of Bangladesh Gastroenterology Society gave a welcome address at the beginning of the seminar. Gastroenterologists from all over the country participated and exchanged views in the seminar. The seminar also discussed in detail the Vonoprazan brand ‘Bygerd’ produced by Incepta Pharmaceuticals Limited. Md. Mostofa Kamal Pasha, Deputy General Manager (Marketing) of Incepta Pharmaceuticals Limited, expressed his thanks at the event. Dr. Razibul Alam, professor of Gastroenterology department of BSSMU conducted the seminar. Nuzhat Tarannum, Brand Manager of Incepta Pharmaceuticals Limited-MSD Division gave a presentation on behalf of Incepta.